| 产品详情 |
| Edit |   |
| Product Name | CID 2858522 |
| Description | Purity ~98% (HPLC). Selectively inhibits protein kinase C (PKC)-induced activation of the NF-kappaB pathway (IC50 < 0.1um for PMA-stimulated IL-8 production). Inhibits antigen receptor-stimulated NF-kappaB activation in chronic lymphocytic leukemia (CLL) B cells. Does not inhibit other NF-kappaB pathways, including that activated by tumor necrosis factor (TNF). Sequence: C28H39N3O3 Solubility: DMSO (~20mM), Ethanol (~20mM) Molecular Weight: ~465.63 |
| Size | 10mg |
| Concentration | n/a |
| Applications | n/a |
| Other Names | CID 2858522 (Selectively Inhibits PKC-induced NF-kB Activation, 1-[3,5-Bis(1,1-dimethylethyl)-4-hyd roxyphenyl]-2-[2-[(3-hydroxypropyl)amino]-5,6-dime thyl-1H-benzimidazol-1-yl]ethanone) |
| Gene, Accession, CAS # | n/a |
| Catalog # | 145668 |
| Price | |
| Order / More Info | CID 2858522 from UNITED STATES BIOLOGICAL |
| Product Specific References | n/a |
| 产品资料 |
|
|